Health & Fitness
Fri, January 27, 2012
STEVENSON, Md.--([ BUSINESS WIRE ])--The law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Micromet, Inc. (aMicrometa) (NASDAQ: MITI) and other violations of state law by the board of directors of Micromet relating to the proposed acquisition of the company by Amgen. The firmas investigation seeks to determine, among other things, whether the board breached their fiduciary duties by failing to maximize shareholder value.
On January 26, 2012, Micromet and Amgen announced that they have entered into a definitive merger agreement providing for Amgen to acquire Micromet for $11 per share in cash. According to the press release, the transaction values Micromet at approximately $1.16 billion. However, according to Bloomberg, at least one analyst has set a price target of $12.00 per share for Micromet stock.
If you currently own shares of Micromet and would like to learn more about the investigation being conducted by Brower Piven, you may email or call Brower Piven, who will, without obligation or cost to you, attempt to answer your questions. You may contact Brower Piven by email at [ hoffman@browerpiven.com ], by calling (410) 415-6616, or at Brower Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven have combined experience litigating securities and other class action cases of over 60 years.
